Dr Elizabeth Sumner Spivey, PHD | |
121 W 3rd St, Suite 203, Yankton, SD 57078 | |
(605) 668-2222 | |
(605) 668-2222 |
Full Name | Dr Elizabeth Sumner Spivey |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 121 W 3rd St, Yankton, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538101043 | NPI | - | NPPES |
0040573 | Other | SD | BLUE CROSS BLUE SHIELD |
9204887 | Other | SD | DAKOTACARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 260 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Elizabeth Sumner Spivey, PHD Po Box 526, 121 W 3rd Suite 203, Yankton, SD 57078 Ph: (605) 668-2222 | Dr Elizabeth Sumner Spivey, PHD 121 W 3rd St, Suite 203, Yankton, SD 57078 Ph: (605) 668-2222 |
News Archive
When it comes to prostate cancer, there's a lot of confusion about how to prevent it, find it early and the best way - or even whether - to treat it. Below are six common prostate cancer myths along with research-based information from scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.
On Feb. 2, the final day of the second annual SNM Clinical Trials Network Workshop, experts working in various facets of the molecular imaging community met in Albuquerque, N.M., to discuss the nuts and bolts of using imaging in clinical trials and the challenges and opportunities ahead in the regulatory landscape.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian, fallopian tube and primary peritoneal cancers.
Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.
› Verified 1 days ago
Dr. William Douglas Pierce, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1000 W 4th St, Yankton, SD 57078 Phone: 605-665-0258 | |
Erick Messler, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 327 Broadway Ave Ste 13, Yankton, SD 57078 Phone: 605-661-0095 | |
Dr. Richard W. Sellars, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3515 Broadway Ave., Yankton, SD 57078 Phone: 605-668-3100 | |
Alexandra L Pagel, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2703 Fox Run Parkway, Suite 200, Yankton, SD 57078 Phone: 605-665-0258 Fax: 605-665-2707 | |
Joseph G Blackinton, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Heartland Psychological Services, 904 W 23rd St Ste 101, Yankton, SD 57078 Phone: 605-665-0841 Fax: 605-665-0096 | |
Lina M. Hall, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3515 Broadway Ave, Yankton, SD 57078 Phone: 605-668-3100 Fax: 605-668-3460 |